A retrospective study of treatment persistence and adherence to mirabegron versus antimuscarinics, for the treatment of overactive bladder in Spain

BACKGROUND: Persistence on-treatment with antimuscarinics in patients with overactive bladder (OAB) is reported to be sub-optimal. This retrospective, longitudinal, observational cohort study assessed treatment persistence with β(3)-adrenoceptor agonists (i.e. mirabegron) and antimuscarinics, both c...

Descripción completa

Detalles Bibliográficos
Autores principales: Nazir, Jameel, Hakimi, Zalmai, Guelfucci, Florent, Khemiri, Amine, Fatoye, Francis, Blázquez, Ana María Mora, González, Marta Hernández
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6122705/
https://www.ncbi.nlm.nih.gov/pubmed/30180826
http://dx.doi.org/10.1186/s12894-018-0390-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6122705/
https://www.ncbi.nlm.nih.gov/pubmed/30180826
http://dx.doi.org/10.1186/s12894-018-0390-z

Ejemplares similares